| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-510X(00)00464-0 |
| P698 | PubMed publication ID | 11137520 |
| P50 | author | Paolo Livrea | Q43084896 |
| Isabella Laura Simone | Q43731286 | ||
| Maria Liguori | Q47419442 | ||
| Carla Tortorella | Q57118161 | ||
| P2093 | author name string | A Bellacosa | |
| P Giannini | |||
| F Federico | |||
| D Carrara | |||
| V Lucivero | |||
| P2860 | cites work | Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 |
| Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 | ||
| Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies | Q28304567 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations | Q35456727 | ||
| The pathological evolution of multiple sclerosis | Q35850662 | ||
| 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis | Q36317451 | ||
| Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport | Q37701379 | ||
| Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging | Q46324186 | ||
| Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis. | Q48106705 | ||
| Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions | Q48182289 | ||
| The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio | Q48274750 | ||
| Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. | Q48279741 | ||
| Proton magnetic resonance spectroscopy in primary blepharospasm | Q48390384 | ||
| Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. | Q48408024 | ||
| Imaging axonal damage of normal-appearing white matter in multiple sclerosis. | Q48486976 | ||
| Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. | Q48511548 | ||
| Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. | Q48550799 | ||
| Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. | Q48588737 | ||
| Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects. | Q48641594 | ||
| Axonal damage in acute multiple sclerosis lesions. | Q48776354 | ||
| Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. | Q48789208 | ||
| High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. | Q48844459 | ||
| Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. | Q48851784 | ||
| Total brain N-acetylaspartate: a new measure of disease load in MS. | Q52082948 | ||
| Magnetization transfer ratio changes in a symptomatic lesion of a patient at presentation with possible multiple sclerosis | Q57912053 | ||
| Prognostic Value of Proton Magnetic Resonance Spectroscopy in Ischemic Stroke | Q60464580 | ||
| Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. | Q62601724 | ||
| Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis | Q68289771 | ||
| Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites | Q69656580 | ||
| Lactate production by human monocytes/macrophages determined by proton MR spectroscopy | Q72059146 | ||
| Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images | Q72059941 | ||
| Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis | Q72605880 | ||
| Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis | Q74575038 | ||
| P433 | issue | 2 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 143-150 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of the Neurological Sciences | Q6296168 |
| P1476 | title | Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study | |
| P478 | volume | 182 |
| Q34570124 | Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability? |
| Q55088439 | Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches. |
| Q34991066 | Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression? |
| Q36348623 | Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions |
| Q84778568 | Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale |
| Q45922762 | Extensive vasogenic edema of anti-aquaporin-4 antibody-related brain lesions. |
| Q41476817 | Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model |
| Q31027957 | Magnetic resonance spectroscopy in the monitoring of multiple sclerosis |
| Q33621304 | Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging |
| Q36198630 | Metabolic profile of PML lesions in patients with and without IRIS: an observational study |
| Q37256993 | Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis |
| Q34444673 | NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review |
| Q48122818 | Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging |
| Q31015190 | Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T. |
| Q91707553 | Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker |
| Q36474335 | Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis |
| Q44624953 | Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy |
Search more.